A booster dose of the Pfizer-BioNTech vaccine provides protection against omicron that is similar to a two-dose course against the original strain of the coronavirus, the companies said Wednesday based on preliminary lab studies.
A booster dose of the Pfizer-BioNTech vaccine provides protection against omicron that is similar to a two-dose course against the original strain of the coronavirus, the companies said Wednesday based on preliminary lab studies.
Omicron, the latest coronavirus variant with a Greek name, features a buffet of mutations suggesting it will spread faster, stiff-arm vaccines to some degree and bind tighter to human cells but scientists aren't hitting the panic button yet.
Omicron, the latest coronavirus variant with a Greek name, features a buffet of mutations suggesting it will spread faster, stiff-arm vaccines to some degree and bind tighter to human cells but scientists aren't hitting the panic button yet.
The European Union's drug regulator on Thursday authorized Pfizer's coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent.